FibriCheck welcomed Cristina Marinescu as a new Product Owner.

FibriCheck is a digital health company transforming how cardiac care is delivered, through a CE-certified (CE1639), FDA-cleared remote heart monitoring ecosystem accessible from any smartphone. Users track heart rate, heart rhythm, blood pressure, weight, symptoms, and heart health indicators such as heart age and heart rate variability. Regular monitoring, combined with contextual information, helps detect conditions before they progress to serious outcomes such as stroke or heart failure. Results can be shared directly with physicians, speeding up diagnosis and treatment. Our pathway integrations show how FibriCheck fits across the full user journey, from early detection to post-treatment monitoring. FibriCheck delivers value across the full member population: healthy members stay engaged by tracking wellness parameters, at-risk members benefit from early, highly accurate detection, symptomatic members get objective rhythm data to correlate with their symptoms, and diagnosed members are empowered to manage their condition long-term. Built-in educational resources drive engagement throughout. We partner with leading insurers who use FibriCheck to reduce unnecessary doctor visits and to lower claims from late-stage diagnosis. Regulatory rigor, clinical validation, and GDPR compliance are non-negotiable for us. FibriCheck is regulated as a medical device and authorized for use in the EU (CE1639), US (FDA-cleared), UK, Australia, Singapore and Hong Kong, and is backed by over a decade of clinical validation and a growing body of 100+ peer-reviewed publications. Today, FibriCheck is used across more than 2,000 clinical practices and trusted by over 1.5 million users across 5 continents, with flexible integration options for providers, insurers, and payers. 🧑‍🏫 Learn about PPG technology: bit.ly/3XmqU7r 🤝 Explore collaboration: bit.ly/43h0UwQ 📚 Read our ebook on heart health for insurers: bit.ly/3ThXg5o 💡 Get the latest news and updates: bit.ly/3MF0ybM